University of Alabama Birmingham Sleuths Finds Drug Candidate Against COVID-19
June 11, 2020
June 11, 2020
BIRMINGHAM, Alabama, June 11 -- The University of Alabama Birmingham campus issued the following news:
The medical detectives at the Hugh Kaul Precision Medicine Institute at the University of Alabama at Birmingham helped find a potential drug to treat COVID-19. Degarelix, a Food and Drug Administration-approved drug for prostate cancer, is now undergoing a clinical trial to see if it can prevent the SARS-CoV-2 virus from entering lung tissue.
The double-blind randomize . . .
The medical detectives at the Hugh Kaul Precision Medicine Institute at the University of Alabama at Birmingham helped find a potential drug to treat COVID-19. Degarelix, a Food and Drug Administration-approved drug for prostate cancer, is now undergoing a clinical trial to see if it can prevent the SARS-CoV-2 virus from entering lung tissue.
The double-blind randomize . . .